Ligand profile
TPR
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02286 — Thymidylate synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
TPR- PDB
1f4e- UniProt (similar protein)
P0A884- Target protein
- KP13_02286
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 74.7
- −1 ≤ LogP ≤ 5 1.23
- MW ≤ 500 Da 269.3
- LogP ≤ 5 1.23
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 74.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(cc1)S(=O)(=O)[N@]2CCC[C@@H]2C(=O)OCc1ccc(cc1)S(=O)(=O)[N@]2CCC[C@@H]2C(=O)O
InChI=1S/C12H15NO4S/c1-9-4-6-10(7-5-9)18(16,17)13-8-2-3-11(13)12(14)15/h4-7,11H,2-3,8H2,1H3,(H,14,15)/t11-/m1/s1InChI=1S/C12H15NO4S/c1-9-4-6-10(7-5-9)18(16,17)13-8-2-3-11(13)12(14)15/h4-7,11H,2-3,8H2,1H3,(H,14,15)/t11-/m1/s1
CGPHGPCHVUSFFA-LLVKDONJSA-NCGPHGPCHVUSFFA-LLVKDONJSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00303
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TPR →
- PDB RCSB structure 1f4e →
- UniProt UniProt P0A884 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TPR”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02286.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).